Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to VON: 5-Azacytidine: a new anticancer drug with effectiveness in acute myelogenous leukemia. (0.11 sec) 

5-Azacytidine: a new anticancer drug with effectiveness in acute myelogenous leukemia


H VON… - Annals of Internal Medicine, 1976 - Am Coll Physicians
Clinical studies involving 5-azacytidine, a ring analogue of cytidine, began in
Europe in 1967 and the United States in 1970, and we review available
preclinical and clinical studies here. The drug possesses cytotoxic, ...
Cited by 86 - Related articles - All 2 versions

5-Azacytidine (NSC 102816): a new drug for the treatment of myeloblastic leukemia

- hematologylibrary.org [PDF] 
WR Vogler, DS Miller, JW Keller - Blood, 1976 - bloodjournal.hematologylibrary.org
. Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ...
Cited by 40 - Related articles - All 4 versions

A comparative clinical trial of 5-azacytidine and guanazole in previously treated adults …


JA Levi, PH Wiernik - CA A Cancer Journal for Clinicians - interscience.wiley.com
Adults with previously treated acute nonlymphocytic leukemia received either
5-azacytidine or guanazole in a randomized study. Eighteen patients were treated
with 5-azacytidine at a dosage of 200-250 mg/m 2 /day × 5 intravenously ...
Cited by 31 - Related articles - All 2 versions

5-Azacytidine: a new active agent for the treatment of acute leukemia

- bloodjournal.org [PDF] 
M Karon, L Sieger, S Leimbrock, JZ … - Blood, 1973 - Am Soc Hematology
. Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ...
Cited by 80 - Related articles - All 3 versions

5-azacytidine in acute leukemia


JH Saiki, KB McCredie, TJ Vietti, JS Hewlett, … - CA A Cancer Journal for Clinicians - interscience.wiley.com
101 patients with acute leukemia in relapse were treated with 5-azacytidine
according to three schedules: Regimen A - 300 mg/m 2 (day divided intravenously
at 8 hour intervals for 5 days; Regimen B - 750 mg/m 2 as a single iv pulse ...
Cited by 39 - Related articles - All 2 versions

[CITATION] Treatment of acute leukemia with 5-azacytidine (NSC-102816).


KB McCredie, GP Bodey, MA Burgess, JU … - Cancer chemotherapy reports. Part 1 - ncbi.nlm.nih.gov
1: Cancer Chemother Rep. 1973 Sep-Oct;57(3):319-23. Treatment of acute leukemia
with 5-azacytidine (NSC-102816). McCredie KB, Bodey ...
Cited by 33 - Related articles

Phase specificity of 5-azacytidine against mammalian cells in tissue culture

- aacrjournals.org [PDF] 
LH Li, EJ Olin, TJ Fraser, BK Bhuyan - Cancer research, 1970 - AACR
5-Azacytidine (1 to 5 jug/ml) significantly inhibited mitosis of L1210 cells in
culture only after 2 hr of incubation. The inhibition of mitosis was correlated
to the inhibition of DNA synthesis. With asynchronous DON and LI210 cells, ...
Cited by 38 - Related articles - All 2 versions

[CITATION] Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816).


RE Bellet, MJ Mastrangelo, PF Engstrom, JG … - Cancer chemotherapy reports. Part 1 - ncbi.nlm.nih.gov
1: Cancer Chemother Rep. 1974 Mar-Apr;58(2):217-22. Clinical trial with
subcutaneously administered 5-azacytidine (NSC-102816). ...
Cited by 27 - Related articles

The disposition and pharmacokinetics in humans of 5-azacytidine administered intravenously …

- aacrjournals.org [PDF] 
ZH Israili, WR Vogler, ES Mingioli, JL Pirkle, … - Cancer Research, 1976 - AACR
The disposition of 5-[4-4C]azacytidine, administered iv as a bolus or continuous
infusion, was studied in cancer patients. After bolus, plasma ‘4Clevels
exhibited a multi phasic disappearance pattern; half-life (t1,2, /3 phase) ...
Cited by 35 - Related articles - All 2 versions

[CITATION] Azacitidine in myelodysplastic syndromes: CALGB studies 8421 and 8921


L Silverman, JF Holland, E Demakos… - Ann Hematol, 1994
Cited by 37 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google